Return to homepagePandemic Pact

National Clinical Study Group (NKSG) Post-Covid Syndrome and ME/CFS

  • Funded by Federal Ministry of Research, Technology and Space (BMFTR)
  • Total publications:5 publications

Grant number: 01EP2201

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2022
    2024

  • Known Financial Commitments (USD)

    $9,683,708.27

  • Funder

    Federal Ministry of Research, Technology and Space (BMFTR)

  • Research Location

    Germany

  • Lead Research Institution

    Charité - Universitätsmedizin Berlin

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Post acute and long term health consequences

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

5 Publications linked via Europe PMC

Last Updated:2 days ago

View all publications at Europe PMC

Cross-platform clinical proteomics using the Charité open standard for plasma proteomics (OSPP).

Low blood levels of selenium, selenoprotein P and GPx3 are associated with accelerated biological aging: results from the Berlin Aging Study II (BASE-II).

Randomized controlled double-blind trial of methylprednisolone versus placebo in patients with post-COVID-19 syndrome and cognitive deficits: study protocol of the post-corona-virus immune treatment (PoCoVIT) trial.

Observational Study of Repeat Immunoadsorption (RIA) in Post-COVID ME/CFS Patients with Elevated ß2-Adrenergic Receptor Autoantibodies-An Interim Report.

Fighting Post-COVID and ME/CFS - development of curative therapies.